The need for dynamic models of drug markets1
P. Reuter
The dynamic character of drug problems
J.P. Caulkins
Key variables and data requirements in modelling drug systems
E. Single
A mover-stayer type model for epidemics of problematic drug use
C. Rossi
The dynamic process of dynamic modelling: the cocaine epidemic in the United States of America
Doris Behrens-Abouseif, Gernot Tragler
Pharmaco-economics of drug addiction: estimating the costs of hepatitis C virus, hepatitis B virus and human immunodeficiency virus infection among injecting drug users in member States of the European Union*
M. J. Postma, Lambert Wiesing, Johannes C. Jager
Controlling infectious diseases among injection drug users: learning (the right) lessons from acquired immunodeficiency syndrome (AIDS)
Henry Pollack
Age-specific multi-state drug initiation models: insights from considering heterogeneity*
C. Almeder, J.P. Caulkins, G. Feichtinger, Gernot Tragler
The epidemiology of drug use at the macro level: indicators, models and policy-making*
Lambert Wiesing, R. Hartnoll, C. Rossi
Incidence indicators for policy-making: models, estimation and implications
L. Ravà, M.G. Calvani, S. Heisterkamp, Lambert Wiesing, C. Rossi
© 2001-2025 Fundación Dialnet · Todos los derechos reservados
Coordinado por: